Honeywell and GranBio have partnered to produce Sustainable Aviation Fuel (SAF) entirely from lignocellulosic biomass, such as forest residues and agricultural waste. By utilizing non-food biomass, this initiative creates a highly scalable pathway to mass-produce renewable aviation fuels that do not compete with global food supplies. This joint venture represents a massive leap toward commercializing second-generation biofuels for heavy transport.
The mixed agricultural and wood residues undergo mechanical pretreatment and enzymatic hydrolysis to break down tough cellulose into fermentable sugars. These sugars are fermented into cellulosic ethanol using GranBio's proprietary technology. This ethanol is then fed into Honeywell’s Alcohol-to-Jet (ATJ) catalytic process, where it is dehydrated, oligomerized, and hydrogenated to form complex, aviation-grade hydrocarbon chains (Synthetic Paraffinic Kerosene).
Heavy industries like steel manufacturing are highly dependent on mined fossil coal as both a thermal fuel and a chemical reductant to strip oxygen from iron ore. This project focuses on converting woodchips and crop residues into a high-carbon alternative known as bio-coal. By substituting fossil coke with this renewable, engineered biomass, metal producers can drastically reduce their Scope 1 carbon emissions while maintaining the intense heat required for metal smelting ("Green Steel").
Woodchips undergo high-temperature torrefaction or slow pyrolysis in an oxygen-deprived environment (typically between 250°C and 400°C). This thermal degradation drives off moisture and volatile compounds, leaving behind a dense, hydrophobic, high-carbon solid. This bio-coal is then briquetted or pelletized to match the physical density, crush-resistance, and chemical profile of traditional metallurgical coke.
Historically, the chemical precursors for many common pharmaceuticals, such as paracetamol, are derived from coal tar or crude oil derivatives. This breakthrough process utilizes the complex lignin structure found in woodchips to synthesize these exact chemical compounds. By creating a bio-based supply chain for pharmaceutical ingredients, the medical industry can decouple its life-saving drugs from petrochemical dependency, ensuring a greener and more resilient healthcare supply chain.
Woodchips are processed using a specialized catalytic fractionation technique that breaks down the tough lignin polymer into specific phenolic monomers (such as p-hydroxycinnamic acid). These isolated bio-intermediates are then subjected to continuous flow chemistry, where they are selectively oxidized and amidated to produce pharmaceutical-grade acetaminophen without the use of toxic, fossil-based industrial solvents.
